Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats
- PMID: 3407549
- DOI: 10.1007/BF01968100
Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats
Abstract
Possible chemical mediators contributing to 48 hour passive cutaneous anaphylaxis (PCA) in rats were investigated. Forty-eight hour PCA was inhibited considerably by mepyramine and methysergide given intravenously, a finding suggestive of a major role for histamine and serotonin in the reaction. AA-861, a selective 5-lipoxygenase inhibitor did not inhibit the PCA, and leukotriene (LT)D4 or LTE4 and the combination with prostaglandin (PG)E2 had no significant skin reaction. In addition, only small amounts of slow reacting substance of anaphylaxis (SRS-A) were detected in skin fragments, in vitro. Although CV-3988, a selective platelet activating factor (PAF) antagonist, dose-dependently inhibited the PAF-induced skin reaction, the PCA was not affected by treatment with this compound. Indomethacin also had no inhibitory activity on PCA. Thus, sulfidopeptide LTs, PAF and arachidonate cyclooxygenase metabolites probably do not contribute to PCA, at least in rats.
Similar articles
-
Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear.J Pharmacobiodyn. 1990 May;13(5):272-7. doi: 10.1248/bpb1978.13.272. J Pharmacobiodyn. 1990. PMID: 2177106
-
Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis.Eur J Pharmacol. 1991 Nov 5;204(2):157-63. doi: 10.1016/0014-2999(91)90700-z. Eur J Pharmacol. 1991. PMID: 1687219
-
Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats.Jpn J Pharmacol. 1988 Feb;46(2):189-92. doi: 10.1254/jjp.46.189. Jpn J Pharmacol. 1988. PMID: 3379829
-
Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear.Int Arch Allergy Appl Immunol. 1986;80(3):285-90. doi: 10.1159/000234067. Int Arch Allergy Appl Immunol. 1986. PMID: 3087885
-
Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.Pharmacology. 1989;39(1):19-27. doi: 10.1159/000138567. Pharmacology. 1989. PMID: 2479953
Cited by
-
The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators.Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):663-9. doi: 10.1007/BF00167245. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8133909
-
PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis.Inflammation. 1991 Oct;15(5):347-54. doi: 10.1007/BF00917351. Inflammation. 1991. PMID: 1757122
-
Inhibition of hind-paw edema and cutaneous vascular plasma extravasation by 2-chloro-3-methoxycarbonylpropionamido-1,4-naphthoquinone (PP1D1) in mice.Naunyn Schmiedebergs Arch Pharmacol. 1996 Dec;354(6):779-84. doi: 10.1007/BF00166905. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8971739